Rat Model of Fractionated (2 Gy/day) 60 Gy Irradiation of the Liver: Long-term Effects
Overview
Environmental Health
Oncology
Radiology
Authors
Affiliations
The liver is considered a radiosensitive organ. However, in rats, high single-dose irradiation (HDI) showed only mild effects. Consequences of fractionated irradiation (FI) in such an animal model have not been studied so far. Rats were exposed to selective liver FI (total dose 60 Gy, 2 Gy/day) or HDI (25 Gy) and were killed three months after the end of irradiation. To study acute effects, HDI-treated rats were additionally killed at several time points between 1 and 48 h. Three months after irradiation, no differences between FI and HDI treatment were found for macroscopically detectable small "scars" on the liver surface and for an increased number of neutrophil granulocytes distributed in the portal fields and through the liver parenchyma. As well, no changes in HE-stained tissues or clear signs of fibrosis were found around the portal vessels. Differences were seen for the number of bile ducts being increased in FI- but not in HDI-treated livers. Serum levels indicative of liver damage were determined for alkaline phosphatase (AP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltransferase (γGT) and lactate dehydrogenase (LDH). A significant increase of AP was detected only after FI while HDI led to the significant increases of AST and LDH serum levels. By performing RT-PCR, we detected up-regulation of matrix metalloproteinases, MMP-2, MMP-9, MMP-14, and of their inhibitors, TIMP-1, TIMP-2 and TIMP-3, shortly after HDI, but not at 3 month after FI or HDI. Overall, we saw punctual differences after FI and HDI, and a diffuse formation of small scars at the liver surface. Lack of "provisional clot"-formation and absence of recruitment of mononuclear phagocytes could be one explanation for scar formation as incomplete repair response to irradiation.
Fu X, Li T, Yao Q Front Oncol. 2022; 12:811183.
PMID: 35433490 PMC: 9007236. DOI: 10.3389/fonc.2022.811183.
Ramos I, Dias M, Nunes De Moraes A, Meireles Ferreira F, Souza S, Gutfilen B Front Pharmacol. 2021; 12:725084.
PMID: 34867327 PMC: 8634713. DOI: 10.3389/fphar.2021.725084.
Transient Inhibition of mTORC1 Signaling Ameliorates Irradiation-Induced Liver Damage.
Yang W, Shao L, Zhu S, Li H, Zhang X, Ding C Front Physiol. 2019; 10:228.
PMID: 30984007 PMC: 6449701. DOI: 10.3389/fphys.2019.00228.
Radiation-induced liver disease: current understanding and future perspectives.
Kim J, Jung Y Exp Mol Med. 2017; 49(7):e359.
PMID: 28729640 PMC: 5565955. DOI: 10.1038/emm.2017.85.
Role of PECAM-1 in radiation-induced liver inflammation.
Malik I, Stange I, Martius G, Cameron S, Rave-Frank M, Hess C J Cell Mol Med. 2015; 19(10):2441-52.
PMID: 26177067 PMC: 4594685. DOI: 10.1111/jcmm.12630.